UB Paderborn / Katalog / Suche / in CDI

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Journal of clinical oncology, 2021-10, Vol.39 (30), p.3391-3402

2021

Volltextzugriff (PDF)

Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer

Modern pathology, 2021-03, Vol.34 (3), p.549-561

2021

Volltextzugriff (PDF)

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

The New England journal of medicine, 2015-05, Vol.372 (21), p.2018-2028

2015

Volltextzugriff (PDF)

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Journal of clinical oncology, 2021-04, Vol.39 (12), p.1349-1359

2021

Volltextzugriff (PDF)

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2016-01, Vol.19 (1), p.42-52

2016

Volltextzugriff (PDF)

Effect of multiple‐dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin

British journal of clinical pharmacology, 2018-12, Vol.84 (12), p.2877-2888

2018

Volltextzugriff (PDF)

The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma

Radiation oncology (London, England), 2019-07, Vol.14 (1), p.116-116, Article 116

2019

Volltextzugriff (PDF)

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2007-11, Vol.25 (33), p.5233-5239

2007

Volltextzugriff (PDF)

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Journal of clinical oncology, 2005-04, Vol.23 (11), p.2493-2501

2005

Volltextzugriff (PDF)

A personality trait contributes to the occurrence of postoperative delirium: a prospective study

BMC psychiatry, 2016-11, Vol.16 (1), p.371-371, Article 371

2016

Volltextzugriff (PDF)

Sentinel lymph node biopsy in acral melanoma: A Korean single‐center experience with 107 patients (2006–2018)

Asia-Pacific journal of clinical oncology, 2021-02, Vol.17 (1), p.115-122

2021

Volltextzugriff (PDF)

Practical Guidelines for Ultrasound-Guided Core Needle Biopsy of Soft-Tissue Lesions: Transformation from Beginner to Specialist

Korean Journal of Radiology, 2017, 18(2), , pp.361-369

2017

Volltextzugriff (PDF)

Bilateral Burow's grafts with a pulley suture: Rapid and simple reconstruction for a large defect on the vertex

Indian journal of dermatology, venereology, and leprology, 2019-07, Vol.85 (4), p.428-430

2019

Volltextzugriff (PDF)

Proximal nail plate destruction in subungual melanoma could be a possible predictor of invasiveness thicker than 1.25 mm

Journal of dermatology, 2018-01, Vol.45 (1), p.83-86

2018

Volltextzugriff (PDF)

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

The New England journal of medicine, 2018-11, Vol.379 (21), p.2027-2039

2018

Volltextzugriff (PDF)

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

Journal of thoracic oncology, 2019-05, Vol.14 (5), p.933-939

2019

Volltextzugriff (PDF)

A multicenter study on extramammary Paget's disease in Korea

International journal of dermatology, 2011-05, Vol.50 (5), p.508-515

2011

Volltextzugriff (PDF)

Light‐Emitting Diode Laser Versus Pulsed Dye Laser‐Assisted Photodynamic Therapy in the Treatment of Actinic Keratosis and Bowen's Disease

Dermatologic surgery, 2012-01, Vol.38 (1), p.151-153

2012

Volltextzugriff (PDF)

First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION Study

JAMA oncology, 2016-03, Vol.2 (3), p.305

2016

Volltextzugriff (PDF)

Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry

Breast (Edinburgh), 2012-02, Vol.21 (1), p.50-57

2012

Volltextzugriff (PDF)

Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.76 (3), p.387-392

2012

Volltextzugriff (PDF)

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

Scientific reports, 2021-01, Vol.11 (1), p.2514-2514

2021

Volltextzugriff (PDF)

Performance of the Geriatric Nutritional Risk Index in predicting 28-day hospital mortality in older adult patients with sepsis

Clinical nutrition (Edinburgh, Scotland), 2013-10, Vol.32 (5), p.843-848

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study

Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer

Effect of multiple‐dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin

The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

A personality trait contributes to the occurrence of postoperative delirium: a prospective study

Sentinel lymph node biopsy in acral melanoma: A Korean single‐center experience with 107 patients (2006–2018)

Practical Guidelines for Ultrasound-Guided Core Needle Biopsy of Soft-Tissue Lesions: Transformation from Beginner to Specialist

Bilateral Burow's grafts with a pulley suture: Rapid and simple reconstruction for a large defect on the vertex

Proximal nail plate destruction in subungual melanoma could be a possible predictor of invasiveness thicker than 1.25 mm

Brigatinib versus Crizotinib in ALK-Positive Non–Small-Cell Lung Cancer

Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

A multicenter study on extramammary Paget's disease in Korea

Light‐Emitting Diode Laser Versus Pulsed Dye Laser‐Assisted Photodynamic Therapy in the Treatment of Actinic Keratosis and Bowen's Disease

First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer: The ASPIRATION Study

Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry

Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era

Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients

Performance of the Geriatric Nutritional Risk Index in predicting 28-day hospital mortality in older adult patients with sepsis

Aktive Filter

Suchergebnisse filtern